| Typicality: | 0.369 |
| Saliency: | 0.484 |
| safely | 5 | manner |
| psilocybin → be administered under → supportive conditions | 8 |
| psilocybin → be used in → controlled clinical environment | 5 |
| negative | neutral | positive |
| 0.006 | 0.402 | 0.593 |
| Raw frequency | 13 |
| Normalized frequency | 0.484 |
| Modifier score | 0.500 |
| Perplexity | 38.303 |